Blog

BioNTech raises $270MA round to fuel mRNA, CAR-T R&D – FierceBiotech


FierceBiotech

BioNTech raises $270MA round to fuel mRNA, CART R&D
FierceBiotech
The syndicate has come together to fund the advance of a multimodality pipeline. BioNTech made its name through its work to identify cancer mutations with the most therapeutic potential and go after them with mRNA treatments of varying degrees of

and more »

2018-01-04 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.